Income Taxes
The Company’s income before provision for income taxes for the years ended July 31, 2017, 2016 and 2015 is as follows:
|
| | | | | | | | | | | |
| Fiscal years ended July 31, |
| 2017 | | 2016 | | 2015 |
| (in thousands) |
Domestic | $ | 26,474 |
| | $ | 11,209 |
| | $ | 11,348 |
|
International | 6,803 |
| | 9,573 |
| | 5,392 |
|
Income before provision for income taxes | $ | 33,277 |
| | $ | 20,782 |
| | $ | 16,740 |
|
The provision for income taxes consisted of the following:
|
| | | | | | | | | | | |
| Fiscal years ended July 31, |
| 2017 | | 2016 | | 2015 |
| (in thousands) |
Current: | | | | | |
U.S. federal | $ | 7,793 |
| | $ | 4,936 |
| | $ | 2,509 |
|
State | 1,974 |
| | 1,006 |
| | 300 |
|
Foreign | 3,595 |
| | 4,350 |
| | 3,910 |
|
Total current | 13,362 |
| | 10,292 |
| | 6,719 |
|
Deferred: | | | | | |
U.S. federal | (686 | ) | | (4,867 | ) | | 983 |
|
State | (429 | ) | | 631 |
| | 169 |
|
Foreign | (194 | ) | | (250 | ) | | (1,016 | ) |
Total deferred | (1,309 | ) | | (4,486 | ) | | 136 |
|
Total provision for income taxes | $ | 12,053 |
| | $ | 5,806 |
| | $ | 6,855 |
|
Differences between income taxes calculated using the statutory federal income tax rate of 35% and the provision for income taxes are as follows:
|
| | | | | | | | | | | |
| Fiscal years ended July 31, |
| 2017 | | 2016 | | 2015 |
| (in thousands) |
Statutory federal income tax | $ | 11,647 |
| | $ | 7,274 |
| | $ | 5,858 |
|
Nondeductible items and other | 2,703 |
| | 2,289 |
| | 1,575 |
|
State income taxes, net of federal benefit | 1,022 |
| | 191 |
| | 388 |
|
Impact of state rate changes | — |
| | 1,132 |
| | — |
|
Foreign income taxed at different rates | 1,513 |
| | 945 |
| | 816 |
|
Tax credits | (4,709 | ) | | (5,963 | ) | | (1,697 | ) |
Change in valuation allowance | (123 | ) | | (62 | ) | | (85 | ) |
Total provision for income taxes | $ | 12,053 |
| | $ | 5,806 |
| | $ | 6,855 |
|
The tax effects of temporary differences that gave rise to significant portions of deferred tax assets and liabilities are as follows:
|
| | | | | | | |
| As of July 31, |
| 2017 | | 2016 |
| (in thousands) |
Accruals and reserves | $ | 11,612 |
| | $ | 11,618 |
|
Stock-based compensation | 8,519 |
| | 6,874 |
|
Deferred revenues | 3,848 |
| | 1,513 |
|
Property and equipment | 1,189 |
| | 1,815 |
|
Net operating loss carryforwards | 16,720 |
| | 10,333 |
|
Tax credits | 11,919 |
| | 12,145 |
|
Total deferred tax assets | 53,807 |
| | 44,298 |
|
Less valuation allowance | 12,583 |
| | 10,505 |
|
Net deferred tax assets | 41,224 |
| | 33,793 |
|
Less deferred tax liabilities: | | | |
Intangible assets | 3,794 |
| | 2,429 |
|
Total net deferred tax assets | $ | 37,430 |
| | $ | 31,364 |
|
During the years ended July 31, 2017, 2016 and 2015, the Company was able to consider positive evidence in determining the realizability of its deferred tax assets, including projections for future growth, and determined a valuation allowance was not required for a significant portion of its deferred tax assets. A valuation allowance of $12.6 million and $10.5 million remained as of July 31, 2017 and 2016, respectively, primarily for California research and development credits and net operating loss carryforwards that were not more likely than not realizable.
As of July 31, 2017, the Company had U. S. federal, California and other states net operating loss (“NOL”) carryforwards of $220.0 million, $68.0 million, and $96.2 million, respectively. The U. S. federal and California NOL carryforwards will start to expire in 2022 and 2018, respectively.
The Company had research and development tax credit (“R&D credit”) carryforwards of the following:
|
| | | | |
| | As of July 31, 2017 |
| | (in thousands) |
U.S. federal | | $ | 21,600 |
|
California | | 22,200 |
|
Total R&D credit carryforwards | | $ | 43,800 |
|
The U.S. federal R&D credit will start to expire in 2023. California R&D tax credits have no expiration.
The excess tax benefits associated with stock option exercises are recorded directly to stockholders’ equity only when realized through reduction to income tax payable on the tax returns. As a result, the pre-tax excess tax benefits included in federal and California net operating loss carryforwards on the tax returns but not reflected in deferred tax assets for fiscal year 2017 are $176.1 million and $50.6 million, respectively.
Federal and California laws impose restrictions on the utilization of net operating loss carryforwards and R&D credit carryforwards in the event of a change in ownership of the Company, which constitutes an “ownership change” as defined by Internal Revenue Code Sections 382 and 383. The Company experienced an ownership change in the past that does not materially impact the availability of its net operating losses and tax credits. Nevertheless, should there be an ownership change in the future, the Company’s ability to utilize existing carryforwards could be substantially restricted.
The Company provides U.S. income taxes on the earnings of foreign subsidiaries, unless the subsidiaries’ earnings are considered indefinitely reinvested outside the United States. As of July 31, 2017, U.S. income taxes were not provided for on the cumulative total of $35.6 million in undistributed earnings from profitable foreign subsidiaries. As of July 31, 2017, the unrecognized deferred tax liability for these earnings was approximately $10.8 million.
Unrecognized Tax Benefits
The following table summarizes the activity related to unrecognized tax benefits:
|
| | | | | | | | | | | |
| Fiscal years ended July 31, |
| 2017 | | 2016 | | 2015 |
| (in thousands) |
Unrecognized tax benefit - beginning of period | $ | 7,687 |
| | $ | 6,109 |
| | $ | 7,976 |
|
Gross increases - prior period tax positions | 712 |
| | 177 |
| | 1 |
|
Gross decreases - prior period tax positions | (691 | ) | | (216 | ) | | (2,896 | ) |
Gross increases - current period tax positions | 1,638 |
| | 1,617 |
| | 1,028 |
|
Unrecognized tax benefit - end of period | $ | 9,346 |
| | $ | 7,687 |
| | $ | 6,109 |
|
During the year ended July 31, 2017, the Company’s unrecognized tax benefits increased by $1.7 million, primarily associated with the Company’s U.S. federal and California R&D tax credits. As of July 31, 2017, the Company had unrecognized tax benefits of $4.0 million that, if recognized, would affect the Company’s effective tax rate.
The Company or one of its subsidiaries files income taxes in the U.S. federal jurisdiction and various states and foreign jurisdictions. If the Company utilizes net operating losses or tax credits in future years, the U.S. federal, state and local, and non-U.S. tax authorities may examine the tax returns covering the period in which the net operating losses and tax credits arose. As a result, the Company’s tax returns in the U.S. and California remain open to examination from fiscal years 2002 through 2017. As of July 31, 2017, the Company has no tax audits in progress in the U.S. and in foreign jurisdictions.